cognitive cybersecurity intelligence

News and Analysis

Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

MALVERN, Pa., May 18, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today…

Source: www.marketscreener.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

UK’s Legal Aid Agency Experiences Cyberattack

A UK Ministry of Justice executive agency was targeted in a cyberattack, compromising its systems. The incident highlights vulnerabilities in cybersecurity, prompting a review of

HIMSSCast: Help with the labor shortage and more can come from tech dealmaking

Berkeley Research Group (BRG) launched its “2025 U.S. Healthcare & Life Sciences Transactions Outlook,” revealing that providers are considering deal activities to tackle AI, cybersecurity,

How telemedicine bridges the rural maternity care gap

The content centers on “Enterprise Taxonomy” related to telehealth, focusing on patient access for rural and underserved communities, as well as population and public health.

LockBit ransomware group falls victim to hackers itself

A data leak has disclosed information about negotiations with victims, Bitcoin wallet addresses, affiliate accounts, and details of attacks.

News and Analysis

Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

Subscribe to newsletter

More Posts

UK’s Legal Aid Agency Experiences Cyberattack

HIMSSCast: Help with the labor shortage and more can come from tech dealmaking

How telemedicine bridges the rural maternity care gap

LockBit ransomware group falls victim to hackers itself

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company